Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × Octreotide × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 6 Neoplasms 4 Carcinoid Tumor 4 Carcinoma 3 Vipoma 2 Neoplasm Metastasis 2 Intestinal Obstruction 2 Carcinoma, Islet Cell 2 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Malignant Carcinoid Syndrome 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gastrinoma 1 Diarrhea 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Ascites 1 Adenoma, Islet Cell 1

Interventions

Oxaliplatin 46 Fluorouracil 43 Leucovorin 40 Capecitabine 36 Bevacizumab 28 Irinotecan 27 Radiotherapy 22 Cetuximab 21 Panitumumab 12 Radiation 11 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 7 Radiotherapy, Intensity-Modulated 6 aflibercept 5 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Chemotherapy, Adjuvant 5 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 XELOX 3 Ramucirumab 3 Neoadjuvant Therapy 3 Fluorodeoxyglucose F18 3 Erlotinib Hydrochloride 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 veliparib 2 trifluridine tipiracil drug combination 2 regorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡